JOSEPH SANDUSKY: Open Payments
NPI 1548547359 · KING, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 36 payments from 10 companies in 2025. Trend: 2023 $924 · 2024 $1,404 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $169 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| PFIZER INC. | 4 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
| Corium, LLC | 1 | $11 |
Products named: REXULTI, BREZTRI, JOURNAVX, NURTEC ODT, Ozempic, Wegovy, Rybelsus, FARXIGA.
Industry payments across NC — which companies pay providers there.
